Chung Wu Investment Group LLC Invests $272,000 in Intuitive Surgical, Inc. $ISRG

Chung Wu Investment Group LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 500 shares of the medical equipment provider’s stock, valued at approximately $272,000.

A number of other large investors also recently bought and sold shares of the stock. Brighton Jones LLC increased its position in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. NBC Securities Inc. purchased a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $135,000. Vest Financial LLC increased its holdings in Intuitive Surgical by 73.5% in the 1st quarter. Vest Financial LLC now owns 4,728 shares of the medical equipment provider’s stock valued at $2,342,000 after purchasing an additional 2,003 shares during the last quarter. Pines Wealth Management LLC purchased a new stake in Intuitive Surgical in the first quarter valued at approximately $216,000. Finally, Sivia Capital Partners LLC lifted its stake in Intuitive Surgical by 7.5% during the first quarter. Sivia Capital Partners LLC now owns 894 shares of the medical equipment provider’s stock worth $443,000 after purchasing an additional 62 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $452.35 on Monday. The firm’s fifty day moving average is $463.55 and its two-hundred day moving average is $500.11. The firm has a market cap of $162.16 billion, a PE ratio of 63.09, a P/E/G ratio of 4.74 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same period last year, the business posted $1.78 EPS. The company’s revenue was up 21.4% on a year-over-year basis. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on ISRG. Royal Bank Of Canada reiterated an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday, August 19th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Saturday, September 27th. UBS Group increased their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 23rd. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Piper Sandler reissued an “overweight” rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Fourteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $594.19.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.